Quarter Ended

September 30,

2021

2020

Earnings per share – basic:

Net earnings, including noncontrolling interest

$

68,981

$

33,395

Less net earnings (loss) attributable to noncontrolling interest

(634

)

-

Net earnings attributable to Bio-Techne

$

69,615

$

33,395

Income allocated to participating securities

(36

)

(21)

Income available to common shareholders

$

69,579

$

33,374

Weighted-average shares outstanding - basic

39,094

38,536

Earnings per share - basic

$

1.78

$

0.87

Earnings per share – diluted:

Net earnings, including noncontrolling interest

$

68,981

$

33,395

Less net earnings (loss) attributable to noncontrolling interest

(634

)

-

Net earnings attributable to Bio-Techne

$

69,615

$

33,395

Income allocated to participating securities

(36

)

(21

)

Income available to common shareholders

$

69,579

$

33,374

Weighted average shares outstanding - basic

39,094

38,536

Dilutive effect of stock options and restricted stock units

2,064

1,489

Weighted average common shares outstanding - diluted

41,158

40,025

Earnings per share - diluted

$

1.69

$

0.83